trial · primary record
E7 TCR-T cells
HPV-Associated Cervical Carcinoma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 15 |
| Primary completion | 2028-10-01 |
| Primary endpoint | Feasibility of administering E7 TCR-T cell therapy as induction treatment for LAHPVC |
| Registry ID | NCT05639972 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:53.827Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05639972
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- E7 Tcr-T Cells · compound